Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

Adv Ther. 2021 Jun;38(6):2935. doi: 10.1007/s12325-021-01744-4.

Authors

Juanzhi Fang¹, Stephanie Korrer², Jonathan C Johnson², Mark A Cheadle³, Roshani Shah³, Matias L Ferraris⁴, Cristina Lopez-Lopez⁴

Affiliations

¹ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. jenny.fang@novartis.com.
² Optum, Eden Prairie, MN, USA.
³ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
⁴ Novartis Pharma AG, Basel, Switzerland.

PMID: 34003453
DOI: 10.1007/s12325-021-01744-4

No abstract available

Publication types

Published Erratum